Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2114120349', 'doi': 'https://doi.org/10.1002/1098-2299(200007/08)50:3/4<211::aid-ddr3>3.0.co;2-g', 'title': 'Dexanabinol (HU-211): A nonpsychotropic cannabinoid with neuroprotective properties', 'display_name': 'Dexanabinol (HU-211): A nonpsychotropic cannabinoid with neuroprotective properties', 'publication_year': 2000, 'publication_date': '2000-01-01', 'ids': {'openalex': 'https://openalex.org/W2114120349', 'doi': 'https://doi.org/10.1002/1098-2299(200007/08)50:3/4<211::aid-ddr3>3.0.co;2-g', 'mag': '2114120349'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/1098-2299(200007/08)50:3/4<211::aid-ddr3>3.0.co;2-g', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S26306840', 'display_name': 'Drug Development Research', 'issn_l': '0272-4391', 'issn': ['0272-4391', '1098-2299'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5016644943', 'display_name': 'Esther Shohami', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I197251160', 'display_name': 'Hebrew University of Jerusalem', 'ror': 'https://ror.org/03qxff017', 'country_code': 'IL', 'type': 'education', 'lineage': ['https://openalex.org/I197251160']}], 'countries': ['IL'], 'is_corresponding': False, 'raw_author_name': 'Esther Shohami', 'raw_affiliation_strings': ['Department of Pharmacology, The Hebrew University, School of Pharmacy, Jerusalem, Israel'], 'affiliations': [{'raw_affiliation_string': 'Department of Pharmacology, The Hebrew University, School of Pharmacy, Jerusalem, Israel', 'institution_ids': ['https://openalex.org/I197251160']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5065631892', 'display_name': 'Raphael Mechoulam', 'orcid': 'https://orcid.org/0000-0002-6122-5698'}, 'institutions': [{'id': 'https://openalex.org/I197251160', 'display_name': 'Hebrew University of Jerusalem', 'ror': 'https://ror.org/03qxff017', 'country_code': 'IL', 'type': 'education', 'lineage': ['https://openalex.org/I197251160']}], 'countries': ['IL'], 'is_corresponding': False, 'raw_author_name': 'Raphael Mechoulam', 'raw_affiliation_strings': ['Department of Medicinal Chemistry, The Hebrew University, School of Pharmacy, Jerusalem, Israel'], 'affiliations': [{'raw_affiliation_string': 'Department of Medicinal Chemistry, The Hebrew University, School of Pharmacy, Jerusalem, Israel', 'institution_ids': ['https://openalex.org/I197251160']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3610, 'currency': 'USD', 'value_usd': 3610, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 2.828, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 39, 'citation_normalized_percentile': {'value': 0.839251, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 90, 'max': 91}, 'biblio': {'volume': '50', 'issue': '3-4', 'first_page': '211', 'last_page': '215'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10414', 'display_name': 'Endocannabinoid System and Its Effects on Health', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10414', 'display_name': 'Endocannabinoid System and Its Effects on Health', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10077', 'display_name': 'Molecular Mechanisms of Synaptic Plasticity and Neurological Disorders', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10800', 'display_name': 'Forensic Toxicology Methods and Analysis', 'score': 0.9776, 'subfield': {'id': 'https://openalex.org/subfields/3005', 'display_name': 'Toxicology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/neurotoxicity', 'display_name': 'Neurotoxicity', 'score': 0.6561569}, {'id': 'https://openalex.org/keywords/cannabinoid-receptors', 'display_name': 'Cannabinoid Receptors', 'score': 0.547259}, {'id': 'https://openalex.org/keywords/nmda-receptors', 'display_name': 'NMDA Receptors', 'score': 0.530946}, {'id': 'https://openalex.org/keywords/endocannabinoid-system', 'display_name': 'Endocannabinoid System', 'score': 0.511711}, {'id': 'https://openalex.org/keywords/neuroprotection', 'display_name': 'Neuroprotection', 'score': 0.500095}], 'concepts': [{'id': 'https://openalex.org/C25498285', 'wikidata': 'https://www.wikidata.org/wiki/Q1981368', 'display_name': 'Neuroprotection', 'level': 2, 'score': 0.85865307}, {'id': 'https://openalex.org/C67018056', 'wikidata': 'https://www.wikidata.org/wiki/Q414896', 'display_name': 'NMDA receptor', 'level': 3, 'score': 0.82401943}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.72336864}, {'id': 'https://openalex.org/C2780871563', 'wikidata': 'https://www.wikidata.org/wiki/Q422936', 'display_name': 'Cannabinoid', 'level': 3, 'score': 0.6990849}, {'id': 'https://openalex.org/C61174792', 'wikidata': 'https://www.wikidata.org/wiki/Q420510', 'display_name': 'Glutamate receptor', 'level': 3, 'score': 0.65918255}, {'id': 'https://openalex.org/C2779491297', 'wikidata': 'https://www.wikidata.org/wiki/Q3338704', 'display_name': 'Neurotoxicity', 'level': 3, 'score': 0.6561569}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.50358266}, {'id': 'https://openalex.org/C148001335', 'wikidata': 'https://www.wikidata.org/wiki/Q421237', 'display_name': 'Cannabinoid receptor', 'level': 4, 'score': 0.45510495}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.33456355}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.324601}, {'id': 'https://openalex.org/C2776885963', 'wikidata': 'https://www.wikidata.org/wiki/Q245204', 'display_name': 'Antagonist', 'level': 3, 'score': 0.32200336}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.30741835}, {'id': 'https://openalex.org/C29730261', 'wikidata': 'https://www.wikidata.org/wiki/Q274160', 'display_name': 'Toxicity', 'level': 2, 'score': 0.18136543}, {'id': 'https://openalex.org/C178790620', 'wikidata': 'https://www.wikidata.org/wiki/Q11351', 'display_name': 'Organic chemistry', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/1098-2299(200007/08)50:3/4<211::aid-ddr3>3.0.co;2-g', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S26306840', 'display_name': 'Drug Development Research', 'issn_l': '0272-4391', 'issn': ['0272-4391', '1098-2299'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.66, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 31, 'referenced_works': ['https://openalex.org/W1489583524', 'https://openalex.org/W18754481', 'https://openalex.org/W1973258967', 'https://openalex.org/W1978636433', 'https://openalex.org/W1985815419', 'https://openalex.org/W1998309270', 'https://openalex.org/W1998929064', 'https://openalex.org/W2006176036', 'https://openalex.org/W2017132655', 'https://openalex.org/W2021037617', 'https://openalex.org/W2024109107', 'https://openalex.org/W2031753342', 'https://openalex.org/W2036099492', 'https://openalex.org/W2042200838', 'https://openalex.org/W2045210813', 'https://openalex.org/W2060463791', 'https://openalex.org/W2064930823', 'https://openalex.org/W2069302043', 'https://openalex.org/W2073871725', 'https://openalex.org/W2078309113', 'https://openalex.org/W2080282837', 'https://openalex.org/W2083792089', 'https://openalex.org/W2091920346', 'https://openalex.org/W2094720192', 'https://openalex.org/W2094807919', 'https://openalex.org/W2138510065', 'https://openalex.org/W2156275638', 'https://openalex.org/W2170217541', 'https://openalex.org/W2316145923', 'https://openalex.org/W2416398154', 'https://openalex.org/W56856103'], 'related_works': ['https://openalex.org/W2938499458', 'https://openalex.org/W2245953918', 'https://openalex.org/W2124754186', 'https://openalex.org/W2079025265', 'https://openalex.org/W2051367597', 'https://openalex.org/W2050501874', 'https://openalex.org/W2048307198', 'https://openalex.org/W2012942066', 'https://openalex.org/W2009732294', 'https://openalex.org/W1991461690'], 'abstract_inverted_index': {'The': [0], 'synthetic': [1], 'cannabinoid': [2], '(+)-(6aS,10aS)-11-hydroxy-Δ-8-tetrahydrocannabinol': [3], '1′,1′-dimethylheptyl': [4], '(dexanabinol,': [5], 'HU-211)': [6], 'is': [7], 'inactive': [8], 'as': [9, 195], 'a': [10, 29, 167, 196], 'cannabimimetic,': [11], 'but': [12, 33], 'exhibits': [13], 'pharmacological': [14], 'properties': [15], 'characteristic': [16], 'of': [17, 37, 46, 55, 74, 104, 150, 169, 193, 201, 231, 234], 'an': [18], 'N-methyl-D-aspartate': [19], '(NMDA)-receptor': [20], 'antagonist.': [21], 'It': [22], 'blocks': [23], 'NMDA-receptors': [24], 'stereospecifically': [25], 'by': [26, 70, 125, 159], 'interacting': [27], 'with': [28], 'site': [30], 'close': [31], 'to,': [32], 'distinct': [34], 'from,': [35], 'that': [36], 'uncompetitive': [38], 'NMDA-receptor': [39], 'antagonists': [40], 'and': [41, 49, 61, 77, 85, 96, 118, 130, 143, 212, 227], 'from': [42, 100, 187], 'the': [43, 53, 79, 101, 148, 154, 173, 181, 190, 228], 'recognition': [44], 'sites': [45], 'glutamate,': [47, 141], 'glycine,': [48], 'polyamines.': [50], 'HU-211': [51, 65, 89, 111, 194, 217], 'inhibits': [52], 'synthesis': [54], 'tumor': [56], 'necrosis': [57], 'factor': [58], 'alpha': [59], '(TNFα)': [60], 'possesses': [62], 'antioxidant': [63], 'properties.': [64], 'blocked': [66], 'NMDA-induced': [67], '45Ca': [68], 'uptake': [69], 'primary': [71], 'neuronal': [72, 81], 'cultures': [73, 82], 'rat': [75, 131], 'forebrain': [76], 'protected': [78, 97], 'same': [80], 'against': [83], 'NMDA': [84], 'glutamate': [86], 'neurotoxicity.': [87], 'Moreover,': [88], 'effectively': [90], 'scavenged': [91], 'peroxy': [92], 'radicals': [93], 'in': [94, 114, 147, 171, 199, 237], 'vitro': [95, 115], 'cultured': [98], 'neurons': [99], 'toxic': [102], 'effects': [103], 'reactive': [105], 'oxygen': [106], 'species': [107], '(ROS).': [108], 'In': [109, 180, 215], 'addition,': [110, 216], 'markedly': [112], 'suppressed': [113], 'TNFα': [116, 144], 'production': [117], 'nitric': [119], 'oxide': [120], '(NO)': [121], 'generation': [122], '(by': [123], '>90%)': [124], 'both': [126], 'murine': [127], 'peritoneal': [128], 'macrophages': [129], 'alveolar': [132], 'macrophage': [133], 'cell': [134], 'line': [135], 'exposed': [136], 'to': [137, 166, 177], 'lipopolysaccharide': [138], '(LPS).': [139], 'Since': [140], 'ROS': [142], 'are': [145, 241], 'implicated': [146], 'pathophysiology': [149], 'various': [151], 'acute': [152], 'conditions,': [153], 'promising': [155], 'results': [156, 186, 230], 'showing': [157], 'neuroprotection': [158], 'HU-211,': [160], 'acting': [161], 'via': [162], 'multiple': [163], 'mechanisms,': [164], 'led': [165], 'series': [168], 'studies': [170], 'which': [172], 'drug': [174], 'was': [175, 218], 'given': [176], 'experimental': [178], 'animals.': [179], 'present': [182], 'review': [183], 'we': [184], 'discuss': [185], 'experiments': [188], 'describing': [189], 'potential': [191], 'use': [192], 'neuroprotective': [197], 'agent': [198], 'models': [200], 'traumatic': [202, 224], 'brain': [203, 225], 'injury,': [204, 208], 'stroke,': [205], 'optic': [206], 'nerve': [207], 'pneumacocal': [209], 'meningitis,': [210], 'sepsis,': [211], 'soman': [213], 'toxicity.': [214], 'introduced': [219], 'into': [220], 'clinical': [221, 235], 'trials': [222, 236], 'for': [223], 'injury': [226], 'successful': [229], 'two': [232], 'phases': [233], 'head': [238], 'injured': [239], 'patients': [240], 'also': [242], 'shown.': [243], 'Drug': [244], 'Dev.': [245], 'Res.': [246], '50:211–215,': [247], '2000.': [248], '©': [249], '2000': [250], 'Wiley-Liss,': [251], 'Inc.': [252]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2114120349', 'counts_by_year': [{'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 2}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-09-25T06:33:10.349188', 'created_date': '2016-06-24'}